Is DARE or DMAC more undervalued in 2026?

CirclFi compares Dare Bioscience, Inc. (DARE) and DiaMedica Therapeutics Inc. (DMAC) using 13 institutional-grade valuation models. DARE has a Quality of Company score of 4.4/10 while DMAC scores 4.7/10.

Which is a better buy — DARE or DMAC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DARE and DMAC valuations compare?

DARE at $2.28 and DMAC at $6.16 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DARE vs DMAC Valuation Comparison 2026 — Intrinsic Value Analysis

DARE

Biotechnology

Dare Bioscience, Inc.

Quality

4.4

out of 10

Value Trap

LOW

Price

$2.28

Last close

Models

9/13

Active

DMAC

Biotechnology

DiaMedica Therapeutics Inc.

Quality

4.7

out of 10

Value Trap

SAFE

Price

$6.16

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	DARE Fair Value	DARE Upside	DMAC Fair Value	DMAC Upside
Bayesian DCF	Intrinsic	$1.22	-46.5%	$1.70	-72.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.93	-59.4%	$0.45	-92.7%
Dynamic NAV	Asset-Based	$2.81	+23.3%	$0.88	-85.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DARE vs DMAC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DARE vs DMAC — Which Stock Is More Undervalued?

DMAC scores higher with a 4.7/10 quality rating vs DARE's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Dare Bioscience, Inc. (DARE) and DiaMedica Therapeutics Inc. (DMAC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DARE currently trades at $2.28 with a QOC of 4.4/10, while DMAC trades at $6.16 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).